Abdominal Cancer Completed Phase 4 Trials for Bupivacaine (DB00297)

IndicationStatusPhase
DBCOND0036156 (Abdominal Cancer)Completed4
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT02566096Efficacy of Transverses Abdominis -Plane Block With Bupivacaine Versus Bupivacaine With Morphine PostoperativelyDiagnostic